ResearcherChina Pharmaceutical UniversityNo recent work listed

Shuping Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4511-2212; OpenAlex author ID A5100641241. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper

Papers 1

Design, synthesis and mechanism studies of novel dual PARP1/BRD4 inhibitors against pancreatic cancer. Last author DOI 10.1016/j.ejmech.2022.114116 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yungen Xu · 1 shared paper, 2022 · strength 0.15
- Paper Design, synthesis and mechanism studies of novel dual PARP1/BRD4 inhibitors against pancreatic cancer. DOI 10.1016/j.ejmech.2022.114116 ↗
Qin Sun · 1 shared paper, 2022 · strength 0.15
- Paper Design, synthesis and mechanism studies of novel dual PARP1/BRD4 inhibitors against pancreatic cancer. DOI 10.1016/j.ejmech.2022.114116 ↗
Shihui Huang · 1 shared paper, 2022 · strength 0.15
- Paper Design, synthesis and mechanism studies of novel dual PARP1/BRD4 inhibitors against pancreatic cancer. DOI 10.1016/j.ejmech.2022.114116 ↗
Shiqi Wu · 1 shared paper, 2022 · strength 0.15
- Paper Design, synthesis and mechanism studies of novel dual PARP1/BRD4 inhibitors against pancreatic cancer. DOI 10.1016/j.ejmech.2022.114116 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.